Contraceptive Compositions With Reduced Adverse Effects
「Contraceptive Compositions With Reduced Adverse Effects」对应一条老挝专利公开记录，由 Estetra SRL 于 2020-04-16 提交申请，当前状态为等待形式审查。标识字段包括：申请号 P/858；DIP 编号 LAP858；主管局代码 LA；保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-02-27。国际分类 / IPC 标注为 A61K 31/565、A61K 31/585、A61K 9/00、A61P 15/18。发明人 / 设计人包括 Jean-Michel FOIDART。代理机构 / 代理人记载为 LAO TRADEMARK AGENCY (LAO IP AGENCY)。公开摘要提示：The present invention relates to a cornbined oral contraceptive with a reduced risk for side effects, including a reduced risk for QT inter…。
The following summary describes a Laos patent titled “Contraceptive Compositions With Reduced Adverse Effects”, filed by Estetra SRL on 2020-04-16; current status: Awaiting formal examination. Identifiers include application No. P/858; DIP id LAP858; protection kind Patent - PCT National Phase. Key dates: publication 2026-02-27. Classification: A61K 31/565、A61K 31/585、A61K 9/00、A61P 15/18. Inventor(s)/designer(s): Jean-Michel FOIDART. Abstract hint: The present invention relates to a cornbined oral contraceptive with a reduced risk for side effects, including a reduced risk for QT inter…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
ໜ້ານີ້ສະຫຼຸບ ສິດທິບັດ «Contraceptive Compositions With Reduced Adverse Effects» ຈາກຂໍ້ມູນຈົດທະບຽນເປີດ, ຍື່ນໂດຍ Estetra SRL ໃນວັນທີ 2020-04-16; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/858; ລະຫັດ DIP LAP858; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-02-27. ປະເພດ/ຫ້ອງ: A61K 31/565、A61K 31/585、A61K 9/00、A61P 15/18. ນັກປະດິດ/ນັກອອກແບບ: Jean-Michel FOIDART. ສະຫຼຸບ: The present invention relates to a cornbined oral contraceptive with a reduced risk for side effects, including a reduced risk for QT inter…. ໃຊ້ LaoBiz ເພື່ອເບິ່ງ IP ອື່ນຂອງຜູ້ຍື່ນຄົນດຽວ ຫຼື ໜ້າວິສາຫະກິດທີ່ກ່ຽວຂ້ອງ.
P/858
图样
基础信息
- 类型
- 专利
- 申请号
P/858- 状态
- 等待形式审查
- 申请人
- Estetra SRL
- 代理机构
- LAO TRADEMARK AGENCY (LAO IP AGENCY)
- 申请日期
- 2020-04-16
- 公开/公告日
- 2026-02-27
- 国际分类
- A61K 31/565 · A61K 31/585 · A61K 9/00 · A61P 15/18
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
The present invention relates to a cornbined oral contraceptive with a reduced risk for side effects, including a reduced risk for QT interval prolongation, a reduced risk for testosterone decrease and a reduced risk for elevated C-reactive protein levels when compared to other contbined oral contraceptives. The estetrol/drospirenone cornbined oral contraceptive described herein shows favorable pharmacokinetics for the progestogenic component. Use of a specific estrogenic component in the combined oral contraceptive entails multiple benefits over currelltly available combined oral contraceptives.
The present invention relates to a cornbined oral contraceptive with a reduced risk for side effects, including a reduced risk for QT interval prolongation, a reduced risk for testosterone decrease and a reduced risk for elevated C-reactive protein levels when compared to other contbined oral contraceptives. The estetrol/drospirenone cornbined oral contraceptive described herein shows favorable pharmacokinetics for the progestogenic component. Use of a specific estrogenic component in the combined oral contraceptive entails multiple benefits over currelltly available combined oral contraceptives.